Activation of Human Platelets by the Membrane-Expressed A1 Domain of von Willebrand Factor
Jan Schulte am Esch II,
Miguel A. Cruz,
Jonathan B. Siegel,
Josef Anrather, and
Simon C. Robson
From the Sandoz Center for Immunobiology and Departments of Medicine and Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, MA; and Department of Hematology and Oncology, Brigham and Womans Hospital, Harvard Medical School, Boston, MA.
Platelet activation and microthrombus formation are invariable features of xenograft rejection and the vascular injury observed when porcine organs are transplanted into primates. This pathological process could be mediated, at least in part, by aberrant interactions of von Willebrand Factor (vWF) associated with the donor vasculature with host platelets. Unlike human vWF, native porcine vWF (pvWF) interacts with human GPIb independently of shear stress or nonphysiological stimuli, eg, ristocetin. We therefore contrasted the potential of isolated human and porcine vWF-A1-domains to interact with human platelets in vitro. Both human and porcine vWF-A1-domains expressed as glycosyl phosphatidylinositol-linked FLAG fusion proteins on COS-7 cells induced GPIb-dependent aggregation and intracellular Ca++ uptake of platelets, independent of both the remainder of the vWF protein and additional modifying factors. Porcine A1-domains were more potent than human homologues, and in addition ristocetin could boost platelet aggregation only with the human A1-domain. Putative conformational changes in the porcine A1-domain could result in the heightened, ristocetin-independent interactions observed with human platelets and may be of importance for xenograft survival.
Blood, Vol. 90 No. 11 (December 1), 1997:
pp. 4425-4437
© 1997 by The American Society of Hematology.
